1H-Isoindole-1,3(2H)-dione, 2-(2,6-dioxo-3-piperidinyl)-4-[[23-[[(4-methylphenyl)sulfonyl]oxy]-3,6,9,12,15,18,21-heptaoxatricos-1-yl]amino]- manufacturers
|
| | 1H-Isoindole-1,3(2H)-dione, 2-(2,6-dioxo-3-piperidinyl)-4-[[23-[[(4-methylphenyl)sulfonyl]oxy]-3,6,9,12,15,18,21-heptaoxatricos-1-yl]amino]- Basic information |
| Product Name: | 1H-Isoindole-1,3(2H)-dione, 2-(2,6-dioxo-3-piperidinyl)-4-[[23-[[(4-methylphenyl)sulfonyl]oxy]-3,6,9,12,15,18,21-heptaoxatricos-1-yl]amino]- | | Synonyms: | 1H-Isoindole-1,3(2H)-dione, 2-(2,6-dioxo-3-piperidinyl)-4-[[23-[[(4-methylphenyl)sulfonyl]oxy]-3,6,9,12,15,18,21-heptaoxatricos-1-yl]amino]-;Thalidomide-?NH-PEG8-OTS;Thalidomide-NH-PEG8-Tos;Pomalidomide-NH-PEG8-Tos;Thalidomide-NH-PEG8-Ts;23-{[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxo-2,3-dihydro-1H-isoindol-4-yl]amino}-3,6,9,12,15,18,21-heptaoxatricosan-1-yl 4-methylbenzene-1-sulfonate | | CAS: | 2488761-07-3 | | MF: | C36H49N3O14S | | MW: | 779.85 | | EINECS: | | | Product Categories: | | | Mol File: | 2488761-07-3.mol | ![1H-Isoindole-1,3(2H)-dione, 2-(2,6-dioxo-3-piperidinyl)-4-[[23-[[(4-methylphenyl)sulfonyl]oxy]-3,6,9,12,15,18,21-heptaoxatricos-1-yl]amino]- Structure](CAS/20200611/GIF/2488761-07-3.gif) |
| | 1H-Isoindole-1,3(2H)-dione, 2-(2,6-dioxo-3-piperidinyl)-4-[[23-[[(4-methylphenyl)sulfonyl]oxy]-3,6,9,12,15,18,21-heptaoxatricos-1-yl]amino]- Chemical Properties |
| Boiling point | 891.4±65.0 °C(Predicted) | | density | 1.317±0.06 g/cm3(Predicted) | | pka | 10.74±0.40(Predicted) |
| | 1H-Isoindole-1,3(2H)-dione, 2-(2,6-dioxo-3-piperidinyl)-4-[[23-[[(4-methylphenyl)sulfonyl]oxy]-3,6,9,12,15,18,21-heptaoxatricos-1-yl]amino]- Usage And Synthesis |
| Uses | Thalidomide-NH-PEG8-Ts is a synthesized E3 ligase ligand-linker conjugate that incorporates the Thalidomide based cereblon ligand and 8-unit PEG linker used in PROTAC technology, such as IDO1 PROTAC degrader (HY-131911)[1]. | | IC 50 | Cereblon | | References | [1] Hu M, et al. Discovery of the first potent proteolysis targeting chimera (PROTAC) degrader of indoleamine 2,3-dioxygenase 1. Acta Pharm Sin B. 2020;10(10):1943-1953. DOI:10.1016/j.apsb.2020.02.010 |
| | 1H-Isoindole-1,3(2H)-dione, 2-(2,6-dioxo-3-piperidinyl)-4-[[23-[[(4-methylphenyl)sulfonyl]oxy]-3,6,9,12,15,18,21-heptaoxatricos-1-yl]amino]- Preparation Products And Raw materials |
|